Prevention of heterotopic ossification after total hip replacement with NSAIDs
| 详细信息 | 推荐本文 | |
- 作者：R. Fijn ; R.Th. Koorevaar and J.R.B.J. Brouwers
- 关键词：COX2 inhibitors ; Diclofenac ; Heterotopic Ossification (HO) ; Indomethacin ; Naproxen ; Nonsteroidal ; antiinflammatory drugs (NSAIDs) ; Rofecoxib
- 刊名：Pharmacy World Science
- 出版时间：2003
- 出版年：2003
- 期刊代码：98_09281231
- 类别：bio
- 卷：25
- 期：4
- 页码：138-145
- 数据来源：sp
摘要
Introduction: non steroidal antiinflammatory drugs ((NSAIDs) and prophylactic radiotherapy can prevent ectopic bone formation around the hip after total hip arthroplasty. Methods: We retrieved from Medline, Embase and the Cochrane Register (clinical)) trials and other relevant literature on the prevention of heterotopic ossification (HO) from 19902002 for further review.Results: Review of these clinical trials shows that HO is effectively prevented by a postoperative NSAID treatment with indomethacin for at least seven days. The best evidence is available for indomethacin, although naproxen, diclofenac and ibuprofen are also well documented. Short term use of ibuprofen is not effective. If NSAIDs are contraindicated, preoperative or postoperative radiotherapy is a very effective therapeutic option to prevent HO. Discussion and conclusion: Because of the potential of serious gastrointestinal side effects of NSAIDs and their interaction with anticoagulant drugs, rofecoxib and other COX2 specific NSAIDs may be a safer option for the treatment of HO. However, randomised controlled studies are needed to confirm the results of the rofecoxib study.